Dr. Suman Malempati MD
Hematologist (Pediatric) | Pediatric Hematology-Oncology
3181 Sw Sam Jackson Park Rd Cdrc-P Portland OR, 97239About
Dr. Malempati cares for children with all varieties of cancer and blood disorders. His clinical expertise is in the treatment of pediatric sarcomas and other solid tumors. Dr. Malempati also heads the ...
Education and Training
Washington Univ Sch Of Med- St Louis Mo 1996
Washington University in St. Louis School of Medicine 1996
Board Certification
PediatricsAmerican Board of PediatricsABP- Pediatric Hematology-Oncology
Provider Details
Clinical Trials
- Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
- A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors
- Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas
- WEE1 Inhibitor AZD1775 and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
- Study of Kidney Tumors in Younger Patients
- Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
- Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
- Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
- Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
- Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
- Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
- Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
- Selumetinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
- Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
- Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Treatments
- Cancer, Blood Disorders
- Anemia
- Bone Cancer
- Acute Myeloid Leukemia (aml)
- Leukemia
- Dermal Aesthetics
- Extra Corporeal Shockwave Therapy
Professional Memberships
- Fellow American Academy of Pediatrics
- Member American Society of Hematology
- Member American Society of Clinical Oncology
- Member American Society of Pediatric Hematology/Oncology
- Member Children's Oncology Group
- Member Histiocyte Society
- Member Oregon Medical Assiociation
Fellowships
- OHSU, Portland, OR,, Pediatric Hematology-Oncology 2002
- Pediatric Hematology/Oncology, Oregon Health & Science University 2005
Dr. Suman Malempati MD's Practice location
Dr. Suman Malempati MD's reviews
Write ReviewPatient Experience with Dr. Malempati
Recommended Articles
- What is A Partial Seizure?
Seizure is a brain abnormality which is caused by a surge in the brain’s electrical activity. It can affect the entire brain and can cause visual disturbances, muscle contractions and blackouts. Partial seizure is described as a seizure which happens in one area of the brain. Partial seizure may...
- Furosemide Side Effects and How to Minimize Them
What is furosemide?Furosemide is an oral prescription medicine, which is available under the brand name Lasix. This drug is also available in its generic form. The generic version of the drug mostly costs less than the branded ones. Furosemide is considered as a water pill or a loop diuretic that...
- Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
- Purpura
PurpuraPurpura refers to purple-colored spots that are usually seen on the skin, including mucous membranes and other organs. It is also called skin hemorrhages or blood spots.Purpura is usually recognized when there is pooling of blood under the skin due to ruptured small blood vessels. The size of...
- How Is Leukemia Diagnosed?
Leukemia in its early stages may present no signs or symptoms, as these only appear when the leukemia cells have taken over a large number of normal blood cells. A person with leukemia is very lucky indeed if early-stage detection occurs incidentally, through a routine blood test or one done for...
- Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients
Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
Nearby Providers
- Dr. Michael Recht MD, PHD707 Sw Gaines St Portland OR 97239
- Dr. Thomas David Lamkin MD3181 Sw Sam Jackson Park Rd Portland OR 97239
- Dr. Susan J Lindemulder MD3181 Sw Sam Jackson Park Rd Portland OR 97239
- Dr. Peter Kurre MD3181 Sw Sam Jackson Park Rd Portland OR 97239
- Dr. Eneida R. Nemecek MD3181 SW SAM JACKSON PARK RD # CDRC-P PORTLAND OR 97239
- Dr. Trisha E Wong MD3181 Sam Jackson Park Road Portland OR 97239